Repurposing FDA-approved drugs as potential PARP inhibitors

被引：0
|
作者：
Eznarriaga, Maria [1 ]
Rahman, Taufiq [1 ]
机构：
[1] Univ Cambridge, Cambridge, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2020年 / 177卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P070
引用
收藏
页码：2516 / 2516
页数：1
相关论文
共 50 条
  • [31] Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
    Abutaleb, Nader S.
    Elhassanny, Ahmed E. M.
    Nocentini, Alessio
    Hewitt, Chad S.
    Elkashif, Ahmed
    Cooper, Bruce R.
    Supuran, Claudiu T.
    Seleem, Mohamed N.
    Flaherty, Daniel P.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 51 - 61
  • [32] Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
    Ray, Abhik Kumar
    Sen Gupta, Parth Sarthi
    Panda, Saroj Kumar
    Biswal, Satyaranjan
    Bhattacharya, Uddipan
    Rana, Malay Kumar
    COMPUTERS IN BIOLOGY AND MEDICINE, 2022, 142
  • [33] Safety of FDA-Approved drugs - Reply
    Friedman, MA
    Woodcock, J
    Lumpkin, MM
    Shuren, JE
    Hass, AE
    Thompson, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2297 - 2298
  • [34] Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection
    Benedict, Ashwini
    Bansal, Neha
    Senina, Svetlana
    Hooper, Idris
    Lundberg, Lindsay
    de la Fuente, Cynthia
    Narayanan, Aarthi
    Gutting, Bradford
    Kehn-Hall, Kylene
    FRONTIERS IN MICROBIOLOGY, 2015, 6
  • [35] Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study
    Jose, Sandra
    Devi, Sreevidya S.
    Sajeev, Anjana
    Girisa, Sosmitha
    Alqahtani, Mohammed S.
    Abbas, Mohamed
    Alshammari, Abdulrahman
    Sethi, Gautam
    Kunnumakkara, Ajaikumar B.
    BIOSCIENCE REPORTS, 2023, 43 (03)
  • [36] An analysis of FDA-approved drugs for oncology
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835
  • [37] NONAPPROVED USES OF FDA-APPROVED DRUGS
    ANDERSON, BJ
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (10): : 1705 - &
  • [38] Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
    Wang, Shaobo
    Liu, Yang
    Guo, Jiao
    Wang, Peilin
    Zhang, Leike
    Xiao, Gengfu
    Wang, Wei
    JOURNAL OF VIROLOGY, 2017, 91 (21)
  • [39] A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
    Madrid, Peter B.
    Chopra, Sidharth
    Manger, Ian D.
    Gilfillan, Lynne
    Keepers, Tiffany R.
    Shurtleff, Amy C.
    Green, Carol E.
    Iyer, Lalitha V.
    Dilks, Holli Hutcheson
    Davey, Robert A.
    Kolokoltsov, Andrey A.
    Carrion, Ricardo, Jr.
    Patterson, Jean L.
    Bavari, Sina
    Panchal, Rekha G.
    Warren, Travis K.
    Wells, Jay B.
    Moos, Walter H.
    Burke, RaeLyn L.
    Tanga, Mary J.
    PLOS ONE, 2013, 8 (04):
  • [40] Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
    Wu, Peng
    Nielsen, Thomas E.
    Clausen, Mads H.
    DRUG DISCOVERY TODAY, 2016, 21 (01) : 5 - 10
12345